Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

404

Not found

This newslink doesn't exist or it was removed.

Go to Homempage.

Sugerencias de la Hemeroteca

Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop?

Forbes USA Business November 29, 2022

thumbnailGetty Images Key Takeaways Moderna became a household name for creating one of the first COVID-19 vaccines, helping to loosen up pandemic restrictions globally. Moderna’s stock went up during the pandemic for apparent reasons as countries were scrambling to purchase mass... + más

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate

Moderna is suing Pfizer over its coronavirus vaccine | The Verge


Bivalent Antibodies For Covid-19: Two Hands Are Better Than One

Forbes USA Tech January 19, 2023

thumbnailA gymnast grabs two rings - one in each hand.univsport.com The current generation of monoclonal antibodies is ineffective against the predominant variants of SARS-CoV-2 in circulation. Recent studies by Callaway et al. open the possibility that a new type of monoclonal antibody... + más

The Bivalent Booster Protects Against New COVID-19 Variants, New Data Show | Time

FDA Experts Vote to Make All COVID-19 Vaccines and Boosters Bivalent | Time


Moderna sues Pfizer over patents behind COVID-19 vaccine

The Advocate USA Crime October 10, 2022

thumbnailvaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine.Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed... + más

Moderna is suing Pfizer over its coronavirus vaccine | The Verge

Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times


Moderna Says Its RSV Vaccine Trial Was a Success. A Clash With Pfizer and GSK Looms.

MarketWatch USA Business January 18, 2023

thumbnail(ticker: MRNA) said Tuesday its experimental messenger RNA-based RSV vaccine, known as mRNA-1345, was 83.7% effective at preventing less severe disease in adults aged 60 and above, and 82.4% effective at preventing more severe disease. The company only released topline results,... + más

GSK vaccine for older adults granted FDA priority review | Fox Business

Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history | CNBC


Moderna is suing Pfizer over its coronavirus vaccine

The Verge USA Health September 24, 2022

thumbnailModerna is suing Pfizer over its coronavirus vaccineModerna is suing Pfizer over its coronavirus vaccine / The company is filing patent infringement lawsuits against Pfizerp>span:first-child]:text-black text-blurple>By Aug 26, 2022, 12:37 PM UTC Share this story... + más

Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times

Moderna vs. Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | PennLive



About iurex | Privacy Policy | Disclaimer |